Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

4.35
Delayed Data
As of Oct 16
 0.00 / 0.00%
Today’s Change
3.18
Today|||52-Week Range
8.04
+0.93%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Henney Christopher S
Director
Buy1/30/201725,324$4.11$104.1K+3.82%
Love Ted W
Director
Buy2/02/201723,000$4.24$97.5K+0.69%
Myers Scott D /oncothyreon/
President & Chief Executive Officer
Buy1/27/201720,500$3.76$77.1K+13.28%
Myers Scott D /oncothyreon/
President & Chief Executive Officer
Buy8/11/20175,500$3.74$20.6K+19.51%
Myers Scott D /oncothyreon/
President & Chief Executive Officer
Buy5/12/20172,800$4.00$11.2K+4.07%
Fyfe Gwen A
Director
Sale6/24/20172,265$3.78$8.6K+9.57%
Henney Christopher S
Director
Sale6/24/20172,265$3.78$8.6K+9.57%
James Steven P
Director
Sale6/24/20172,265$3.78$8.6K+9.57%
Love Ted W
Director
Sale6/24/20172,265$3.78$8.6K+9.57%
Spiegelman Daniel K
Director
Sale6/24/20172,265$3.78$8.6K+9.57%
Page of 4